Negative attitudes towards robots in the young and old
In: Gerontechnology: international journal on the fundamental aspects of technology to serve the ageing society, Band 21, Heft s, S. 3-3
ISSN: 1569-111X
4 Ergebnisse
Sortierung:
In: Gerontechnology: international journal on the fundamental aspects of technology to serve the ageing society, Band 21, Heft s, S. 3-3
ISSN: 1569-111X
SLAFKA is the world's first blockchain prototype to be developed for a national nuclear regulator. It represents a first step among many in investigating and testing the functionality, usability and acceptability of DLT for nuclear safeguards information management. The report outlines how SLAFKA was developed in line with safeguards legislation and user requirements in Finland to provide a demonstration of how distributed ledger technology (DLT) can be used as a novel method to track nuclear material. SLAFKA demonstrates not only that DLT can cover safeguards transactions and strengthen transparency, data integrity and confidentiality, but also how the inherent characteristics of DLT are suited to the peculiarities and highly governed structure of nuclear safeguards.
BASE
In: Zuberbier , T , Aberer , W , Asero , R , Abdul Latiff , A H , Baker , D , Ballmer-Weber , B , Bernstein , J A , Bindslev-Jensen , C , Brzoza , Z , Buense Bedrikow , R , Canonica , G W , Church , M K , Craig , T , Danilycheva , I V , Dressler , C , Ensina , L F , Giménez-Arnau , A , Godse , K , Gonçalo , M , Grattan , C , Hebert , J , Hide , M , Kaplan , A , Kapp , A , Katelaris , C H , Kocatürk , E , Kulthanan , K , Larenas-Linnemann , D , Leslie , T A , Magerl , M , Mathelier-Fusade , P , Meshkova , R Y , Metz , M , Nast , A , Nettis , E , Oude-Elberink , H , Rosumeck , S , Saini , S S , Sánchez-Borges , M , Schmid-Grendelmeier , P , Staubach , P , Sussman , G , Toubi , E , Vena , G A , Vestergaard , C , Wedi , B , Werner , R N , Zhao , Z & Maurer , M 2018 , ' The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria ' , Allergy: European Journal of Allergy and Clinical Immunology , vol. 73 , no. 7 , pp. 1393-1414 . https://doi.org/10.1111/all.13397
This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-founded network of excellence, the Global Allergy and Asthma European Network (GA²LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO) with the participation of 48 delegates of 42 national and international societies. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria are disabling, impair quality of life and affect performance at work and school. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.
BASE
In: Zuberbier , T , Abdul Latiff , A H , Abuzakouk , M , Aquilina , S , Asero , R , Baker , D , Ballmer-Weber , B , Bangert , C , Ben-Shoshan , M , Bernstein , J A , Bindslev-Jensen , C , Brockow , K , Brzoza , Z , Chong-Neto , H J , Church , M K , Criado , P R , Danilycheva , I V , Dressler , C , Ensina , L F , Fonacier , L , Gaskins , M , Gáspár , K , Gelincik , A , Giménez-Arnau , A , Godse , K , Gonçalo , M , Grattan , C , Grosber , M , Hamelmann , E , Hébert , J , Hide , M , Kaplan , A , Kapp , A , Kessel , A , Kocatürk , E , Kulthanan , K , Larenas-Linnemann , D , Lauerma , A , Leslie , T , Magerl , M , Makris , M , Meshkova , R Y , Metz , M , Micallef , D , Mortz , C G , Nast , A , Oude-Elberink , H , Pawankar , R , Pigatto , P , Ratti Sisa , H , Gutiérrez , M I R , Saini , S S , Schmid-Grendelmeier , P , Sekerel , B E , Siebenhaar , F , Siiskonen , H , Soria , A , Staubach-Renz , P , Stingeni , L , Sussman , G , Szegedi , A , Thomsen , S F , Vadasz , Z , Vestergaard , C , Wedi , B , Zhao , Z & Maurer , M 2022 , ' The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria ' , Allergy: European Journal of Allergy and Clinical Immunology , vol. 77 , no. 3 , pp. 734-766 . https://doi.org/10.1111/all.15090
This update and revision of the international guideline for urticaria was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the Global Allergy and Asthma European Network (GA²LEN) and its Urticaria and Angioedema Centers of Reference and Excellence (UCAREs and ACAREs), the European Dermatology Forum (EDF; EuroGuiDerm), and the Asia Pacific Association of Allergy, Asthma and Clinical Immunology with the participation of 64 delegates of 50 national and international societies and from 31 countries. The consensus conference was held on 3 December 2020. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). Urticaria is a frequent, mast-cell-driven disease that presents with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic urticaria, i.e. chronic spontaneous urticaria and chronic inducible urticaria, is disabling, impairs quality of life, and affects performance at work and school. This updated version of the international guideline for urticaria covers the definition and classification of urticaria and outlines expert-guided and evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.
BASE